Sunday 18 October 2026
Export VTVT’s income statement to Excel — free account
vTv Therapeutics Inc.
VTVT Healthcare Biotechnology
In the quarter to June 2026, revenue grew 409,222.2%, EPS fell 14.1% and free cash flow fell 124.6%, each against the same quarter a year earlier.
26.54
1.05
−3.81%
Follow VTVT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Piotroski F-Score |
1 | 0 | 2 | 2 | 4 | 3 | 3 | — | — | — |
Altman Z-Score |
(7.77) | (20.06) | (46.38) | (43.26) | (29.05) | (14.93) | (11.97) | — | (10.00) | — |
P/S ratio |
75.75 | 201.83 | 2.65 | 18.63 | 13.66 | 15.56 | 27.43 | — | 77.00 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(15.43) | (47.22) | (117.37) | (105.66) | (69.84) | (36.01) | (27.03) | — | (23.51) | — |
P/Operating CF |
(4.20) | (9.28) | (5.62) | (8.76) | (39.64) | (9.71) | (8.08) | — | (16.52) | — |
Beneish M-Score |
— | — | — | — | 12.19 | (3.08) | 0.12 | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 5.57 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 5.57 | — |
EV/Sales |
11.96 | 213.50 | 3.03 | 18.48 | 12.97 | 12.55 | 22.12 | — | 42.82 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
EV/Operating CF |
(0.16) | (1.39) | (1.40) | (2.22) | (4.63) | (2.60) | (2.80) | — | (1.75) | — |
EV/FCF |
(0.16) | (1.39) | (1.40) | (2.24) | (4.69) | (2.64) | (2.78) | — | (1.74) | — |
Quick Ratio |
4.50 | 0.74 | 0.09 | 0.13 | 0.92 | 1.59 | 1.60 | 0.90 | 7.08 | 13.39 |
Current Ratio |
4.56 | 0.76 | 0.18 | 0.21 | 1.13 | 1.84 | 3.52 | 1.00 | 7.34 | 13.54 |
Net Debt/EBITDA |
0.74 | (0.07) | (0.25) | 0.09 | 0.51 | 0.62 | 0.54 | 0.37 | 1.53 | 2.71 |
Debt/Assets |
20.29% | 54.86% | 73.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.12) | (0.10) | (0.08) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.01 | 0.68 | 0.31 | 0.53 | 0.20 | 0.07 | 0.00 | 0.04 | 0.00 |
Operating CF/Net income |
2.95 | 2.76 | 3.10 | 1.76 | 2.12 | 1.49 | 0.84 | 0.94 | 1.37 | 0.94 |
Capex/Depreciation |
(0.20) | (0.02) | 0.01 | 0.42 | 0.00 | 0.00 | (0.23) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(138.24) | (16.39) | (6.03) | (11.44) | (17.13) | (1,805.17) | (1,502.67) | (1,961.69) | — | (5,468.00) |
| 19.36% | 13.34% | 7.40% | 19.78% | 13.16% | 28.91% | 187.15% | 114.34% | 355.76% | (68.52%) | |
| (22.40%) | (39.18%) | (47.43%) | (146.36%) | (70.66%) | (64.51%) | (65.28%) | (91.51%) | (74.92%) | (42.09%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(39.76%) | 256.91% | 56.56% | 129.38% | (713.00%) | (175.48%) | (97.81%) | (13,064.52%) | (56.04%) | (32.40%) |
Average Days of Receivables |
0.00 | 10,034.36 | 0.00 | 0.66 | 8.99 | 5.19 | 31.29 | 0.00 | 22.25 | — |
Research and Development Expense of Revenue |
7,215.77% | 13,621.99% | 185.26% | 547.00% | 171.73% | 332.68% | 612.34% | 0.00% | 1,135.30% | 0.00% |
Selling, General and Administrative Expense of Revenue |
1,562.46% | 3,894.50% | 74.18% | 308.86% | 113.05% | 308.19% | 604.61% | 0.00% | 1,342.28% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
416.56% | 1,252.58% | 21.52% | 54.92% | 15.73% | 58.83% | 63.03% | 0.00% | 271.09% | 0.00% |
Graham Net Nets |
(1.94) | (2.70) | (2.67) | (1.08) | (1.00) | (0.31) | (0.30) | — | 0.18 | — |
Graham Number |
767.98 | 967.96 | 429.54 | 190.06 | 107.81 | 35.09 | 35.48 | — | 0.00 | — |
Earnings Yield |
(34.19%) | (27.56%) | (29.06%) | (36.47%) | (10.22%) | (22.11%) | (34.53%) | — | (24.69%) | — |
Free Cash Flow Yield |
(100.63%) | (75.91%) | (81.39%) | (44.24%) | (20.26%) | (30.60%) | (28.98%) | — | (31.86%) | — |
Revenue per Share |
2.66 | 1.20 | 39.96 | 3.65 | 5.44 | 2.56 | 1.05 | 0.00 | 0.18 | 0.00 |
Operating CF per Share |
(201.96) | (183.90) | (86.30) | (30.39) | (15.27) | (12.33) | (8.35) | (9.15) | (4.39) | (3.00) |
Capex per Share |
(0.35) | (0.10) | 0.02 | 0.32 | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(202.31) | (184.01) | (86.28) | (30.08) | (15.27) | (12.33) | (8.36) | (9.15) | (4.39) | (3.00) |
Cash per Share |
215.77 | 49.20 | 5.41 | 2.35 | 4.88 | 8.57 | 6.32 | 4.53 | 6.37 | 10.56 |
Shareholders Equity per Share |
(381.00) | (623.39) | (266.24) | (64.73) | (67.97) | (6.22) | (5.59) | (11.84) | 2.48 | 7.65 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(381.00) | (623.39) | (266.24) | (64.73) | (67.97) | (6.22) | (5.59) | (11.84) | 2.48 | 7.65 |
Free Cash Flow |
(48.29) | (44.58) | (26.85) | (22.78) | (18.00) | (19.31) | (16.04) | (19.08) | (25.31) | (25.25) |
Working Capital |
40.68 | (6.57) | (15.36) | (10.54) | 0.83 | 7.12 | 19.39 | 0.04 | 32.92 | 83.25 |
Capital Expenditures |
(0.08) | (0.02) | 0.01 | 0.24 | — | — | (0.02) | — | — | — |
Net Current Asset Value |
(93.32) | (158.60) | (87.94) | (55.45) | (87.68) | (19.59) | (16.88) | (25.04) | 14.15 | 64.43 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Capex to Sales |
0.13 | 0.09 | 0.00 | (0.09) | 0.00 | 0.00 | 0.01 | — | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.94 | 4.33 | 17.60 | 1.24 | 1.29 | 0.32 | 0.44 | 0.77 | 3.18 | 0.00 |
Cash ROIC |
170.15% | 36.01% | 35.88% | 48.21% | 24.21% | (525.39%) | (1,157.50%) | 125.25% | (49.58%) | (16.47%) |
Accounts Receivable Turnover |
0.00 | 0.07 | 0.00 | 0.69 | 78.70 | 37.26 | 17.55 | 0.00 | 12.40 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | 4.03 | — | 4.00 | 0.08 | 0.11 | 0.12 | 0.14 | 0.08 | — |
Average Payables |
9.46 | 12.66 | 10.80 | 7.39 | 6.59 | 7.07 | 7.67 | 8.78 | 7.63 | 5.79 |
Average Assets |
73.01 | 41.21 | 18.24 | 8.91 | 12.03 | 20.13 | 29.36 | 22.13 | 24.64 | 64.08 |
Average Common Equity |
(84.46) | (121.00) | (116.95) | (65.94) | (64.56) | (44.92) | (10.24) | (17.71) | (5.19) | 39.37 |
Columns are period end dates